the title of the article is self explanatory: High Dose Hydrogen, Magnesium, Bicarbonate Therapy
ph adjust is about the mag/bicarb part. Frankly I wonder if the hydrogen is necessary since bicarb also contains H.
I used to drink h2o2 and I now see it is an inferior protocol to the bicarbs after having tried both. I found I got hydrated with the latter and not the former. I buy mag carbonate and sodium bicararbonate by the kilo . I mix the magcarb with lime and ascorbic acid, then mix that with a sodbicarb, water, lime and stevia solution to taste and drink throughout the day..wonderful. I figure I get enough potassium in my foods already but you could add potassium bicarb if you want. The bicarb part of the molecule is the key to the hydration. Bicarbs are simply natural, powdered limestone.
Afrezza is dried human insulin produced in a lab from recombinant DNA*. The powder is placed into carrier particles (called Technosphere particles) that are so small that once inhaled they can reach your deep lungs, which have the surface area of about half the size of a tennis court. That’s right. A tennis court. Afrezza is absorbed into my blood stream rapidly, peaks in about 12-15 minutes and is out of my system in about 30-45 minutes. It’s so quick that I almost always start eating before I take my insulin. Instead of fast-acting, you can consider Afrezza to be ultra rapid and because of that it more closely mimics the post-meal functions of a person without diabetes.
In rare cases, patients on inhaled fluticasone propionate may present with systemic eosinophilic conditions. Some of these patients have clinical features of vasculitis consistent with Churg-Strauss syndrome , a condition that is often treated with systemic corticosteroid therapy. These events usually, but not always, have been associated with the reduction and/or withdrawal of oral corticosteroid therapy following the introduction of fluticasone propionate. Cases of serious eosinophilic conditions have also been reported with other inhaled corticosteroids in this clinical setting. Physicians should be alert to eosinophilia , vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal relationship between fluticasone propionate and these underlying conditions has not been established.